Esperion Therapeutics Inc (ESPR)
2.12
+0.04
(+1.92%)
USD |
NASDAQ |
May 06, 16:00
2.15
+0.03
(+1.42%)
After-Hours: 18:51
Esperion Therapeutics Free Cash Flow: -135.49M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -135.49M |
| September 30, 2023 | -140.90M |
| June 30, 2023 | -164.41M |
| March 31, 2023 | -190.19M |
| December 31, 2022 | -174.83M |
| September 30, 2022 | -190.06M |
| June 30, 2022 | -216.40M |
| March 31, 2022 | -213.73M |
| December 31, 2021 | -263.81M |
| September 30, 2021 | -274.65M |
| June 30, 2021 | -292.16M |
| March 31, 2021 | -104.90M |
| December 31, 2020 | -98.55M |
| September 30, 2020 | -67.49M |
| June 30, 2020 | -39.28M |
| March 31, 2020 | -232.33M |
| December 31, 2019 | -71.29M |
| September 30, 2019 | -49.92M |
| June 30, 2019 | -29.11M |
| March 31, 2019 | -14.07M |
| December 31, 2018 | -148.79M |
| September 30, 2018 | -154.87M |
| June 30, 2018 | -153.18M |
| Date | Value |
|---|---|
| March 31, 2018 | -140.21M |
| December 31, 2017 | -131.32M |
| September 30, 2017 | -112.85M |
| June 30, 2017 | -91.27M |
| March 31, 2017 | -72.35M |
| December 31, 2016 | -47.82M |
| September 30, 2016 | -40.10M |
| June 30, 2016 | -37.70M |
| March 31, 2016 | -39.01M |
| December 31, 2015 | -38.48M |
| September 30, 2015 | -38.03M |
| June 30, 2015 | -34.97M |
| March 31, 2015 | -32.79M |
| December 31, 2014 | -32.89M |
| September 30, 2014 | -32.21M |
| June 30, 2014 | -28.14M |
| March 31, 2014 | -24.90M |
| December 31, 2013 | -18.14M |
| September 30, 2013 | -12.97M |
| June 30, 2013 | -11.10M |
| March 31, 2013 | -10.75M |
| December 31, 2012 | -10.82M |
Free Cash Flow Range, Past 5 Years
-292.16M
Minimum
Jun 2021
-29.11M
Maximum
Jun 2019
-155.24M
Average
-164.41M
Median
Jun 2023
Free Cash Flow Benchmarks
| United Therapeutics Corp | 752.40M |
| Dynavax Technologies Corp | 96.46M |
| Heron Therapeutics Inc | -60.33M |
| Aldeyra Therapeutics Inc | -30.33M |
| Deciphera Pharmaceuticals Inc | -147.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -37.06M |
| Cash from Financing (Quarterly) | 4.471M |
| Free Cash Flow Per Share (Quarterly) | -0.3294 |
| Free Cash Flow to Equity (Quarterly) | -37.49M |
| Free Cash Flow Yield | -62.04% |